A, I., F, Y., A, F., Y, I., G, S., M, M., . . . H, U. Effect of Imeglimin, a Novel Anti-Diabetic Agent, on Insulin Secretion and Glycemic Variability in Type 2 Diabetes Treated with DPP-4 Inhibitor: A 16-Week, Open Label, Pilot Study. Dove Medical Press.
Chicago Style (17th ed.) CitationA, Itsukaichi, Yoshikawa F, Fuchigami A, Iwata Y, Sato G, Miyagi M, Hirose T, and Uchino H. Effect of Imeglimin, a Novel Anti-Diabetic Agent, on Insulin Secretion and Glycemic Variability in Type 2 Diabetes Treated with DPP-4 Inhibitor: A 16-Week, Open Label, Pilot Study. Dove Medical Press.
MLA (9th ed.) CitationA, Itsukaichi, et al. Effect of Imeglimin, a Novel Anti-Diabetic Agent, on Insulin Secretion and Glycemic Variability in Type 2 Diabetes Treated with DPP-4 Inhibitor: A 16-Week, Open Label, Pilot Study. Dove Medical Press.